[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Mass Spectrometry for Clinical Diagnostics Applications 2013 Focus Report

June 2013 | 73 pages | ID: M95B89EB5C8EN
Select Biosciences Ltd.

US$ 1,318.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The SELECTBIO Mass Spectrometry for Clinical Diagnostics Applications: 2013 Focus Report is the latest industry report describing in detail the expanding list of applications of mass spectrometry in the diagnostics space. All the data presented in this report is based upon primary market research performed by research analysts at SELECTBIO in 2013 and therefore represents a current, up-to-date view of the marketplace.

Topics Addressed in this Report:
  • Market Segmentation, Market Landscape, and Mass Spectrometry Products Currently on the Market as well as in Development
  • Market Segments offering Opportunity in this Space
  • Diagnostic Areas Impacted by Mass Spectrometry as well as Laboratory Developed Tests (LDTs) and In vitro Diagnostics (IVDs) based on Mass Spectrometry
  • CLIAC Recommendations
  • Collaborations and Partnerships in the Mass Spectrometry for Clinical Diagnostics Space
  • Pipeline of Grants Awarded for Technology Development in the Mass Spectrometry for Clinical Diagnostics Space
  • Mass Spectrometry and Approaches of Relevance to Clinical Diagnostics
  • Institutional Rankings of Companies in this Space offering Products for Clinical Diagnostics
This Report from SELECTBIO is delivered in PowerPoint format to customers enabling convenient cut-and-paste into R&D presentations, business plans, and investor presentations.
CHAPTER I. MARKET SEGMENTATION, LANDSCAPE, AND PRODUCTS

MS Market Segmentation
Developed and Marketed MS Systems
MS Systems Under Development Currently
MS Multiplexing
Front-End Sample Preparation for MS

CHAPTER II. DIAGNOSTIC AREAS IMPACTED AND PRODUCTS AVAILABLE

Laboratory Developed Tests (LDTs) based on MS Detection
In Vitro Diagnostics (IVDs) based on MS Detection
CLIAC Recommendations
Attractive Market Segments in the MS-bascd Diagnostics Space
Collaborations and Partnerships in the MS-based Clinical Diagnostics Space
Grants in the MS-bascd Clinical Diagnostics Space

APPENDIX I. MASS SPECTROMETRY TECHNOLOGIES AND APPROACHES

Of Relevance to Clinical Diagnostics Space


More Publications